MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung CancerFrancesca Fanini, Muller Fabbri|International Journal of Molecular Sciences|2021Cited by 13